Treatment with cinacalcet increases plasma sclerostin concentration in hemodialysis patients with secondary hyperparathyroidism

[1] Krishnan V(2006)Regulation of bone mass by Wnt signaling J Clin Invest 116 1202-1209

[2] Bryant HU(2013)Sclerostin as a potential novel biomarker for aortic valve calcification: an in-vivo and ex-vivo study J Heart Valve Dis 22 317-325

[3] Macdougald OA(2013)Novel insights into osteogenesis and matrix remodelling associated with calcific uraemic arteriolopathy Nephrol Dial Transplant 28 856-868

[4] Koos R(2001)Bone dysplasia sclerosteosis results from loss of the SOST gene product, a novel cystine knot-containing protein Am J Hum Genet 68 577-589

[5] Brandenburg V(2002)Identification of a 52 kb deletion downstream of the SOST gene in patients with van Buchem disease J Med Genet 39 91-97

[6] Mahnken AH(2005)Chronic elevation of parathyroid hormone in mice reduces expression of sclerostin by osteocytes: a novel mechanism for hormonal control of osteoblastogenesis Endocrinology 146 4577-4583

[7] Kramann R(2010)Serum sclerostin levels negatively correlate with parathyroid hormone levels and free estrogen index in postmenopausal women J Clin Endocrinol Metab 95 1991-1997

[8] Brandenburg VM(2013)Sclerostin: another vascular calcification inhibitor? J Clin Endocrinol Metab 98 3221-3228

[9] Schurgers LJ(2013)The relation between renal function and serum sclerostin in adult patients with CKD Clin J Am Soc Nephrol 8 819-823

[10] Brunkow ME(2014)Clinical and biological determinants of sclerostin plasma concentration in hemodialysis patients Nephron Clin Pract 128 127-134

[1] Krishnan V(2006)Regulation of bone mass by Wnt signaling J Clin Invest 116 1202-1209

[2] Bryant HU(2013)Sclerostin as a potential novel biomarker for aortic valve calcification: an in-vivo and ex-vivo study J Heart Valve Dis 22 317-325

[3] Macdougald OA(2013)Novel insights into osteogenesis and matrix remodelling associated with calcific uraemic arteriolopathy Nephrol Dial Transplant 28 856-868

[4] Koos R(2001)Bone dysplasia sclerosteosis results from loss of the SOST gene product, a novel cystine knot-containing protein Am J Hum Genet 68 577-589

[5] Brandenburg V(2002)Identification of a 52 kb deletion downstream of the SOST gene in patients with van Buchem disease J Med Genet 39 91-97

[6] Mahnken AH(2005)Chronic elevation of parathyroid hormone in mice reduces expression of sclerostin by osteocytes: a novel mechanism for hormonal control of osteoblastogenesis Endocrinology 146 4577-4583

[7] Kramann R(2010)Serum sclerostin levels negatively correlate with parathyroid hormone levels and free estrogen index in postmenopausal women J Clin Endocrinol Metab 95 1991-1997

[8] Brandenburg VM(2013)Sclerostin: another vascular calcification inhibitor? J Clin Endocrinol Metab 98 3221-3228

[9] Schurgers LJ(2013)The relation between renal function and serum sclerostin in adult patients with CKD Clin J Am Soc Nephrol 8 819-823

[10] Brunkow ME(2014)Clinical and biological determinants of sclerostin plasma concentration in hemodialysis patients Nephron Clin Pract 128 127-134